Background: The rapidly increasing global prevalence of e-cigarette use, particularly among adolescents and young adults, has raised significant concern regarding their respiratory safety. E-cigarettes generate an aerosol by heating a liquid mixture containing nicotine, propylene glycol, vegetable glycerin, flavorings, and various toxic and potentially carcinogenic compounds such as aldehydes, acrolein, and heavy metals. The respiratory system, being the primary route of exposure, is especially vulnerable to both acute and chronic toxic effects. Aims: This review aims to synthesize and critically evaluate current evidence on the respiratory consequences of e-cigarette use, with a focus on acute and chronic pulmonary effects, underlying cellular and molecular mechanisms of injury, and implications for public health and clinical practice. Methods: A narrative review was conducted following a structured literature search in PubMed, Scopus, Web of Science, and Embase for studies published between 2018 and 2025. The search included the terms “e-cigarette”, “vaping”, “respiratory system”, “lung injury”, “EVALI”, “oxidative stress”, “nicotine”, and “pulmonary disease”. The initial search identified 246 records; after screening and eligibility assessment, 74 studies were included. Priority was given to systematic reviews, meta-analyses, and large-scale observational or experimental studies. Data were synthesized narratively with emphasis on methodological rigor, quality of evidence, and consistency of findings. Results: E-cigarette use was shown to cause both acute and chronic respiratory injury. Acute effects include airway inflammation, oxidative stress, and epithelial barrier disruption, while chronic exposure is linked to persistent inflammation, bronchial remodeling, and increased risk of asthma and chronic obstructive pulmonary disease. The 2019 EVALI outbreak exemplified the acute toxicity potential, particularly from illicit THC-containing products adulterated with vitamin E acetate. Experimental studies confirm mitochondrial dysfunction and DNA damage, indicating genotoxic and pro-carcinogenic mechanisms already in progress. Epidemiological data consistently show higher prevalence of respiratory symptoms and reduced lung function among e-cigarette users compared with non-users, including those who have never smoked combustible cigarettes. However, interpretation must remain cautious due to methodological heterogeneity, self-reported exposure data, and limited long-term follow-up. Conclusions: Current evidence demonstrates that e-cigarettes are not harmless and should be recognized as independent respiratory risk factors. Although they differ from conventional tobacco products, they induce distinct pathophysiological effects mediated by oxidative stress, inflammation, and epithelial dysfunction. The long-term carcinogenic potential remains uncertain because of limited longitudinal data, yet biomarker evidence indicates possible genotoxicity. Persistent research gaps include the long-term impact of novel flavoring agents, standardized exposure assessment, and dose–response relationships. Continuous high-quality longitudinal research and stronger regulatory measures are essential to mitigate health risks and protect vulnerable populations.